Trial Profile

Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Glucagon (Primary)
Indications Hypoglycaemia
Focus Therapeutic Use
Acronyms The HYPO-AVOID STUDY

Most Recent Events

30 Jun 2024 Status changed from recruiting to completed.
17 Apr 2024 Number of treatment arms are increased from 1 to 2 by he addition of a control arm. Study design is changed from single group assignment to sequential.
17 Apr 2024 Planned End Date changed from 11 Dec 2023 to 13 May 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com